BoneScreen | Disease detection | Digital biomarkers | AI

Bonescreen is a TU Münich spin-out company enabling opportunistic disease detection” of patients CT-scan for additional diseases. bonescreen’s identified digital biomarkers combined with AI-supported analysis tools detect early stages of osteoporosis. Bonescreen enables early diagnosis and early therapeutic treatment – with higher probability of best clinical outcome for patients.

We defined core tasks and addressed them in prepared team coaching / workshop sessions:

  • Commercial Strategy and Business model development
  • IP Strategy development
  • HCP stakeholder identification and engagement
  • Review of soft-funding grant applications
  • Selecting key profiles for Board of Directors

Bonescreen is part of the EIT Health Wild Card programme. Bonescreen’s founders selected me as Lead Mentor, with weekly mentoring sessions.